Financials

  • Market Capitalization 4.57 M
  • Employee 5
  • Founded 2018
  • CEO N/A
  • Website www.ernexatx.com
  • Headquarter Delaware, United States
  • FIGI BBG000CX5677
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.96
Price to sales ratio
281.44

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4959
CDIO
Cardio Diagnostics Holdings Inc. - Common stock
1.62 USD+5.19%-3.57%-19.40%-38.29%4.79 M USD
4961
SILO
Silo Pharma Inc -, effectuated 1:50 R/S on 9/15
4.40 USD-1.35%-9.28%-26.17%+547.06%4.77 M USD
4971
EVGN
Evogene Ltd. - Ordinary Shares
0.52 USD-3.70%-5.45%+33.33%-58.73%4.53 M USD
4972
LIMN
Liminatus Pharma, Inc. - Class A Common Stock
0.10 USD-9.09%-9.09%-9.09%-98.72%4.49 M USD

Frequently asked questions about Ernexa Therapeutics Inc. - Common Stock

What is the Ernexa Therapeutics Inc. - Common Stock stock price today?

The current price of Ernexa Therapeutics Inc. - Common Stock (ERNA) is 3.92. Over the past 24 hours, the stock has changed by -0.25%. Follow the ERNA chart for real-time price dynamics.

What is the stock ticker of Ernexa Therapeutics Inc. - Common Stock?

Ernexa Therapeutics Inc. - Common Stock trades under the ticker ERNA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Ernexa Therapeutics Inc. - Common Stock stock going up?

ERNA has changed by -24.76% over the last week, -41.14% over the last month, and +1021.60% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Ernexa Therapeutics Inc. - Common Stock net income for the last quarter?

Ernexa Therapeutics Inc. - Common Stock reported net income of -5.51 M for the last quarter. The previous quarter showed -1.5 M, which means net income changed by -266.33%.

How many employees does Ernexa Therapeutics Inc. - Common Stock have?

As of the latest available data, Ernexa Therapeutics Inc. - Common Stock has 5 employees. Workforce size can provide additional context about the company's scale and operations.

What is Ernexa Therapeutics Inc. - Common Stock EBITDA?

Ernexa Therapeutics Inc. - Common Stock EBITDA is -5.57 M, and its EBITDA margin is -39.77 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Ernexa Therapeutics Inc. - Common Stock stock?

You can buy Ernexa Therapeutics Inc. - Common Stock (ERNA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Ernexa Therapeutics Inc. - Common Stock stock?

Investing in Ernexa Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ERNA chart and related analysis on metatrader.com as part of your research.

News